MiMedx Group Statistics
Total Valuation
MiMedx Group has a market cap or net worth of $478.64 million. The enterprise value is $357.84 million.
| Market Cap | 478.64M |
| Enterprise Value | 357.84M |
Important Dates
The last earnings date was Wednesday, October 28, 2026, after market close.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MiMedx Group has 145.93 million shares outstanding. The number of shares has decreased by -1.32% in one year.
| Current Share Class | 145.93M |
| Shares Outstanding | 145.93M |
| Shares Change (YoY) | -1.32% |
| Shares Change (QoQ) | -1.31% |
| Owned by Insiders (%) | 1.90% |
| Owned by Institutions (%) | 58.76% |
| Float | 114.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.62 |
| Forward PS | 1.69 |
| PB Ratio | 2.68 |
| P/TBV Ratio | 2.72 |
| P/FCF Ratio | 25.72 |
| P/OCF Ratio | 23.71 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 19.40 |
Financial Position
The company has a current ratio of 4.35, with zero debt.
| Current Ratio | 4.35 |
| Quick Ratio | 3.67 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.93 |
Financial Efficiency
Return on equity (ROE) is -8.53% and return on invested capital (ROIC) is -26.79%.
| Return on Equity (ROE) | -8.53% |
| Return on Assets (ROA) | -5.38% |
| Return on Invested Capital (ROIC) | -26.79% |
| Return on Capital Employed (ROCE) | -11.35% |
| Weighted Average Cost of Capital (WACC) | 10.70% |
| Revenue Per Employee | $375,905 |
| Profits Per Employee | -$23,752 |
| Employee Count | 808 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 2.84 |
Taxes
| Income Tax | -3.19M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.12% in the last 52 weeks. The beta is 1.17, so MiMedx Group's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | -57.12% |
| 50-Day Moving Average | 4.47 |
| 200-Day Moving Average | 4.26 |
| Relative Strength Index (RSI) | 21.62 |
| Average Volume (20 Days) | 1,670,871 |
Short Selling Information
The latest short interest is 9.26 million, so 6.35% of the outstanding shares have been sold short.
| Short Interest | 9.26M |
| Short Previous Month | 9.36M |
| Short % of Shares Out | 6.35% |
| Short % of Float | 8.06% |
| Short Ratio (days to cover) | 7.99 |
Income Statement
In the last 12 months, MiMedx Group had revenue of $303.73 million and -$19.19 million in losses. Loss per share was -$0.13.
| Revenue | 303.73M |
| Gross Profit | 234.75M |
| Operating Income | -25.14M |
| Pretax Income | -22.38M |
| Net Income | -19.19M |
| EBITDA | -17.31M |
| EBIT | -25.14M |
| Loss Per Share | -$0.13 |
Balance Sheet
The company has $120.79 million in cash and no debt, with a net cash position of $120.79 million or $0.83 per share.
| Cash & Cash Equivalents | 120.79M |
| Total Debt | n/a |
| Net Cash | 120.79M |
| Net Cash Per Share | $0.83 |
| Equity (Book Value) | 211.08M |
| Book Value Per Share | 1.45 |
| Working Capital | 144.20M |
Cash Flow
In the last 12 months, operating cash flow was $20.74 million and capital expenditures -$1.62 million, giving a free cash flow of $19.12 million.
| Operating Cash Flow | 20.74M |
| Capital Expenditures | -1.62M |
| Depreciation & Amortization | 7.83M |
| Net Borrowing | -18.25M |
| Free Cash Flow | 19.12M |
| FCF Per Share | $0.13 |
Margins
Gross margin is 77.29%, with operating and profit margins of -8.28% and -6.32%.
| Gross Margin | 77.29% |
| Operating Margin | -8.28% |
| Pretax Margin | -7.37% |
| Profit Margin | -6.32% |
| EBITDA Margin | -5.70% |
| EBIT Margin | -8.28% |
| FCF Margin | 6.30% |
Dividends & Yields
MiMedx Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.32% |
| Shareholder Yield | 1.32% |
| Earnings Yield | -3.97% |
| FCF Yield | 3.89% |
Analyst Forecast
The average price target for MiMedx Group is $7.00, which is 113.42% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 113.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | -7.07% |
| EPS Growth Forecast (3Y) | -33.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MiMedx Group has an Altman Z-Score of 9.44 and a Piotroski F-Score of 2.
| Altman Z-Score | 9.44 |
| Piotroski F-Score | 2 |